Non-diabetic patients with genetic variants in GIPR and FTO, or MC4R pathways may benefit from precision dosing strategies that maximize efficacy while minimizing side effects, making personalized testing particularly valuable for optimizing outcomes
This benefit often outweighs any transient elevation during initial therapy phases
Sterile water without preservative should only be used for single-dose vials that will be fully consumed immediately after reconstitution
Key findings included: Statistically significant erectile responses at doses above 7 mg compared to placebo Onset of first erection occurring approximately 30 minutes post-administration Mean duration of adequate erection rigidity increasing from 18 minutes to 73 minutes at higher doses Efficacy in approximately one-third of men who had inadequate response to sildenafil Studies using subcutaneous administration (1.0-10.0 mg) in men with inadequate Viagra response demonstrated dose-dependent improvements in penile rigidity and erectile function
Storage and handling directly impact potency, which impacts results
Antidiabetic drugs and sarcopenia: Emerging links, mechanistic insights, and clinical implications